Page last updated: 2024-09-03

pd 135158 and loxiglumide

pd 135158 has been researched along with loxiglumide in 2 studies

Compound Research Comparison

Studies
(pd 135158)
Trials
(pd 135158)
Recent Studies (post-2010)
(pd 135158)
Studies
(loxiglumide)
Trials
(loxiglumide)
Recent Studies (post-2010) (loxiglumide)
5100257549

Protein Interaction Comparison

ProteinTaxonomypd 135158 (IC50)loxiglumide (IC50)
Cholecystokinin receptor type AHomo sapiens (human)0.195

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fölsch, UR; Höcker, M; Hughes, J; Schmidt, WE1
Blackmore, M; Doherty, E; Hirst, BH; Manning, JE1

Other Studies

2 other study(ies) available for pd 135158 and loxiglumide

ArticleYear
PD 135158, a CCKB/gastrin receptor antagonist, stimulates rat pancreatic enzyme secretion as a CCKA receptor agonist.
    European journal of pharmacology, 1993, Sep-21, Volume: 242, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Cholecystokinin; Drug Interactions; Indoles; Lipase; Meglumine; Pancreas; Proglumide; Rats; Sincalide

1993
Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
    International journal of cancer, 1994, May-01, Volume: 57, Issue:3

    Topics: Benzamides; Benzodiazepinones; Cell Division; Devazepide; Gastrins; Humans; Indoles; Kidney Neoplasms; Meglumine; Phenylurea Compounds; Proglumide; Receptors, Cholecystokinin; Tumor Cells, Cultured; Wilms Tumor

1994